DAK-Gesundheit claim that cost saving measures imposed by the GVK Financial Stabilisation Act are un...
Read moreGermany's BPI and vfa advise that the implementation of the European Health Technology Assessment (E...
Read moreOur market access experts cover the changes to the joint EU HTA process that occurred in 2022 and wh...
Read moreThis law is projected to have a large impact on the pharmaceutical industry and pharmacies nationwid...
Read moreThe pricing dynamics of biosimilars, depends on the type of biosimilar, its indication and the chann...
Read moreThis updated bill contains some similar measures to those proposed in March as well as some addition...
Read moreEUnetHTA and the EU Joint HTA Process EUnetHTA was established in 2006 to facilitate information sha...
Read moreEUnetHTA and the EU Joint HTA Process Originally set up in 2006, EUnetHTA was established to facilit...
Read morePRIME medicines include CAR T-cell therapies, one-time potentially curative gene therapies, rare can...
Read moreThe proposals are set out in the draft Statutory Health Insurance Financial Stabilisation Bill which...
Read more